Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Debt (2019 - 2026)

Mimedx's Non-Current Debt history spans 10 years, with the latest figure at $16.1 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 8.21% to $16.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.1 million, a 8.21% decrease, with the full-year FY2025 number at $16.5 million, down 7.64% from a year prior.
  • Non-Current Debt hit $16.1 million in Q1 2026 for Mimedx, down from $16.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for MDXG hit a ceiling of $49.0 million in Q3 2023 and a floor of $16.1 million in Q1 2026.
  • Historically, Non-Current Debt has averaged $32.1 million across 5 years, with a median of $18.5 million in 2024.
  • Biggest five-year swings in Non-Current Debt: increased 1.01% in 2023 and later crashed 63.2% in 2024.
  • Tracing MDXG's Non-Current Debt over 5 years: stood at $48.6 million in 2022, then dropped by 1.02% to $48.1 million in 2023, then tumbled by 62.93% to $17.8 million in 2024, then dropped by 7.64% to $16.5 million in 2025, then fell by 2.27% to $16.1 million in 2026.
  • Business Quant data shows Non-Current Debt for MDXG at $16.1 million in Q1 2026, $16.5 million in Q4 2025, and $16.8 million in Q3 2025.